With many humbling and worthy nominations to choose from, three New Zealand lockdown heroes stood out for their compassion, tireless work and can-do attitude in our Maui Jim Nominate a Hero promotion.
Japanese marine biologists have discovered that whale sharks, the world’s largest fish, have teeth-like scales adorning their eyeballs.
A Mexican study has found a smartphone’s night mode may protect users’ eyes from short-wavelength (blue) light more than blue light-reducing lenses.
The American Academy of Ophthalmology (AAO) is launching Ophthalmology Science, its first open access journal focused on pre-clinical development, phase I and II clinical trials, laboratory-based work, ophthalmology informatics and clinical science.
Though the 2020 Association for Research in Vision and Ophthalmology (ARVO) conference was cancelled due to Covid-19, those with accepted abstracts could submit video-recorded presentations and have them published in ARVO’s IOVS (Investigative Ophthalmology and Visual Science) journal. The following
Blind and Low Vision New Zealand’s (BLVNZ’s) new strategic plan puts low vision New Zealanders’ choices at the heart of its services while, for the first time, promising to do more to help people retain their sight.
A group of international researchers are trialling a synthetic gel to repair holes in the cornea, providing a potential alternative to corneal transplant.
A new synthetic cornea that bio-integrates with the eye wall has been given the go-ahead for a corneal transplant trial in Israel, followed by further trials in Canada, the US, France, China and the Netherlands.
Well-known Kiwi glaucoma drainage device company Molteno Ophthalmic has been bought by Nova Eye Medical (formerly Ellex Medical Lasers).
The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) welcomes the new Closing the Gap Agreement announced 30 July 2020. For the first time, there will be targets focused on
Findings from the government’s recently released Health and Disability System Review reveal the poor state of our District Health Board (DHB) assets, especially their IT systems.
More commonly used to treat erectile dysfunction, sildenafil (known best by the trade name Viagra), a phosphodiesterase type 5 inhibitor, could be used to treat ocular hypotension or post-surgical